Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy

Lancet

Volumn 352, Issue 9134, 1998, Pages 1093-1096

  Thomson, Andrew J ^a   Lunan, C Burnett ^a   Ledingham, Marieanne ^a   Howat, Robert C L ^a   Cameron, Lain T ^a   Greer, Ian A ^a   Norman, Jane E ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GEMEPROST; ISOSORBIDE 5 NITRATE; ISOSORBIDE MONONITRATE; NITRIC OXIDE DONOR; PROSTAGLANDIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; FEMALE; FIRST TRIMESTER PREGNANCY; HEADACHE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; OBSTETRIC OPERATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX; VAGINA BLEEDING; VOMITING;

EID: 0032480544     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)01289-6     Document Type: Article

References (29)

1. 2 pessaries to facilitate first trimester aspiration termination. Br J Obstet Gynaecol 1981; 88: 1033-37.
2. Schultz KF, Grimes DA, Cates W. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983; i: 1182-84.
3. Grimes DA, Schultz KF, Cates WJ. Prevention of uterine perforation during curettage abortion. JAMA 1984; 251: 2108-11.
4. Helm CW, Davies N, Beard RJ. A comparison of gemeprost (Cervagem) pessaries and Lamicel tents for cervical preparation for abortion by dilation and suction. Br J Obstet Gynaecol 1988; 95:911-15.
5. Henshaw RC, Templeton AA. Pre-operative cervical preparation before the first trimester vacuum aspiration: a randomised controlled comparison between gemeprost and mifepristone (RU486). Br J Obstet Gynaecol 1991; 98: 1025-30.
6. Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199-206.
7. Buhimschi I, Ali M, Jain V, Chwalisz K, Garfield R. Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 1996; 11: 1755-66.
8. Ali M, Yallampalli C, Chwalisz K, Garfield R. Changes in mRNA levels of nitric oxide synthases in rat uterus and cervix during pregnancy. J Soc Gynaecol Invest 1995; 2: 80.
9. Chwalisz K, Shao-Qing S, Garfield RE, Bier HM. Cervical ripening in guinea-pigs after a local application of nitric oxide. Hum Reprod 1997; 12: 2093-101.
10. Thomson AJ, Lunan CB, Cameron AD, et al. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynaecol 1997; 104: 1054-57.
11. Norman J. Nitric oxide and the myometrium. Pharmacol Ther 1996; 70: 91-100.
12. 1 analogues, misoprostol and gemeprost. Lancet 1994; 343: 1207-09.
13. Anthony GS, Fisher J, Coutts JRT, Calder AA. Forces required for surgical dilation of the pregnant and non-pregnant human cervix. Br J Obstet Gynaecol 1982; 89: 913-16.
14. Richardson W, Smith DC, Evans AL, Anthony GS. A novel cervical dilatation force measurement instrument. J Med Eng Technol 1989; 13: 220-21.
15. Altman DG. How large a sample? In: Gore SM, Altman DG, eds. Statistics in practice. London: British Medical Association, 1982: 6-8.
16. Royal College of Obstetricians and Gynaecologists. Induced abortion: guideline 11, 1997.
17. Lawrie A, Penney G, Templeton A. A randomised comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996; 103: 1117-19.
18. Ngai SW, Yeung KCA, Lao T, Ho PC. Oral misoprostol versus mifepristone for cervical dilation before vacuum aspiration in the first trimester nulliparous pregnancy: a double blind prospective randomised study. Br J Obstet Gynaecol 1996; 103: 1120-23.
19. World Health Organisation. The use of mifepristone (RU486) for cervical preparation in first trimester termination by vacuum aspiration. Br J Obstet Gynaecol 1990; 97: 260-66.
20. Robertson RM, Robertson D. Drugs used in the treatment of cardiac ischaemia. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's pharmacological basis of therapeutics. New York: McGraw Hill, 1995; 759-79.
21. Lees C, Campbell S, Jauniaux E, et al. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 1994; 343: 1325-26.
22. Ramsay B, De Belder A, Campbell S, Moncada S, Martin JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Invest 1994; 24: 76-78.
23. Cotton DB, Longmire S, Jones MJ, Dorman KF, Tesem J, Joyce TH. Cardiovascular alterations in severe pregnancy-induced hypertension: effect of intravenous nitroglycerin coupled with blood volume expansion. Am J Obstet Gynecol 1986; 154: 1053-59.
24. Grunewald C, Kublickas M, Carlstrom K, Lunell NO, Nisell H. Effects of nitroglycerine on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol 1995; 86: 600-04.
25. Thaler I, Amit A, Jakobi P, Itskovitz-Eldor J. The effect of isosorbide dinitrate on uterine artery and umbilical artery flow velocity waveforms in mid-pregnancy. Obstet Gynecol 1996; 88: 838-43.
26. Bulletti C, De Ziegler D, Flamigni C, et al. Targeted drug delivery in gynaecology: the first uterine pass affect. Hum Reprod 1997; 12: 1073-79.
27. Greer IA, Miller M, Calder AA. Gemeprost and cervical ripening: biophysical and histological effects. Eur J Obstet Gynecol Reprod Biol 1992; 47: 1-9.
28. 2 gel for preinduction cervical ripening and labour induction. Am J Obstet Gynecol 1995; 172: 1804-10.
29. Norman JE, Thomson AJ, Greer IA. Cervical ripening after nitric oxide. Hum Reprod 1998; 13: 251-52.